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A B S T R A C T  
 
Objective: To find out the antibiotic susceptibility pattern of gram-negative bacilli isolated from different clinical 
specimens received in a tertiary care hospital at Wah. 
Material and Methods: This cross-sectional study was carried out to determine antibiotic susceptibility pattern of gram-
negative bacilli, cultured from different clinical specimens received in POF Hospital laboratory at Wah. One hundred and 
forty-four clinical isolates of gram-negative rods from different clinical specimens from April 2015 to March 2016 were 
included in the study. All the isolates were processed by standard microbiological methods. The antibiotic susceptibility 
pattern was carried out by disk diffusion method as recommended by Clinical Laboratory Standard Institute guidelines 
(CLSI). 
Results: Out of one hundred and forty-four Gram-negative bacilli, one hundred (69.44%) were from Enterobacteriaceae 
family and forty-four (30.56%) were from non-Enterobacteriaceae group. The commonest isolated organism was 
Escherichia coli (47.3%), followed by Pseudomonas aeruginosa (17.36%) and Acinetobacter baumannii (13.19%). 
These isolates were highly resistant to the most of the commonly prescribed antibiotics. The members of the family 
Enterobacteriaceae showed better sensitivity for amikacin and cefoperazone-sulbactam. Resistance rate for 
carbapenems was significantly high for K.pneumoniae and Proteus mirabilis. Among non-Enterobacteriaceae, 
P.aeruginosa showed better susceptibility for cefoperazone-sulbactam, amikacin, imipenem and meropenem. The multi-
drug resistant pattern was observed for Acinetobacter.baumannii. 
Conclusion: The isolates depict highly resistant patterns to available oral antibiotics as well as commonly prescribed 
injectable third generation cephalosporins and carbapenems. Establishment and implementation of infection control 
practices are required to combat this grave situation. 
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I n t r o d u c t i o n  
 
Antibiotics have enabled tremendous advances in the 
discipline of infectious diseases since their emergence in 
1930. Unfortunately, the occurrence of resistant bacteria 
is endangering the efficacy of antibiotics, which have 
transformed medicine and saved millions of lives.1 The 
infections caused by multiple-drug resistant (MDR) gram-
negative organisms have created entire classes of 
antibiotics redundant and threatened to bring about the 
end of the 'antibiotic era'. 2,3  Extended-spectrum beta-
lactamases, Metallo-beta-lactamases and Amp-C 
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mediated beta-lactamases produced by 
Enterobacteriaceae and other non-lactose fermenters are 
increasingly implicated in outbreaks through the 
dissemination of mobile genetic elements rendering 
emergence of resistant mutants.4 This grave situation 
demands optimization of therapy primarily because of 
substantial increases in the frequency with which these 
organisms affect the health care settings as well as the 
community acquired infections. The challenge of 
heightened antimicrobial resistance among gram-negative 
pathogens has been exacerbated by the stagnation in the 
development of novel antimicrobials. Studies have 
provided convincing evidence that effective initial 
empirical antibiotic therapy, based on ultimate drug 
susceptibility results, improves survival.2  
The constantly evolving antimicrobial resistance patterns 
render antibiotic susceptibility profile in one region at a 
specific period, inapplicable to other region or in another 
period. Thus, antimicrobial susceptibility data from any 
given regional, national, or international surveillance study 
cannot reliably predict the drug resistance profiles of 
pathogens isolated from an individual patient.5 The current 
study was designed to document the commonly isolated 
gram-negative bacilli from different clinical specimens and 
their susceptibility patterns in tertiary health care hospital 
at Wah. This will be an effort to rationalize the empirical 
treatment by clinicians resulting in evidence-based 
practice and better results in terms of early recovery from 
infections, shorter duration of hospitalization and cost 
effectiveness. Moreover, this effort will contribute to 
safeguard the remaining therapeutic options for the 
clinicians and encourage a focused, concerted effort 
against key human pathogens. 
M a t e r i a l  a n d  M e t h o d s  
This cross-sectional study was carried out at Microbiology 
section of Pakistan Ordinance Factories Hospital 
laboratory from April 2015 to March 2016. One hundred 
and forty-four clinical specimens from patients either 
gender, of all ages, yielding growth of Gram-negative 
bacilli were included in the study and selected by 
convenient sampling. Duplicate samples of the same 
patient from the same site were not included.The 
specimens were inoculated on appropriate culture 
medium like blood agar, MacConkey agar, chocolate agar 
(sputum) and cysteine lactose electrolyte deficient agar 
(urine) and incubated at 35-37˚C under aerobic conditions 
for 24 hours. After overnight incubation, the agar plates 
were examined for growth of bacteria and their colonial 
morphology. Gram-negative rods were identified based on 
Gram staining, catalase test, oxidase test and motility.6 
Microbact Gram-negative 24E identification kits (Oxoid, 
Basingstoke, UK) were used for confirmation of isolates. 
Antimicrobial susceptibility tests were performed on the 
Muller–Hinton agar plates with disk diffusion method, as 
recommended by clinical laboratory standards institute.7  
The bacterial suspensions of isolates equivalent to 0.5 
McFarland standard turbidity were applied on Mueller-
Hinton agar (Oxoid, Basingstoke, UK). The antimicrobial 
disks (Oxoid, Basingstoke, UK) were evenly placed on the 
inoculated plates and included Ampicillin (10 µg), 
amoxicillin-clavulanate (20/10 µg), trimethoprin-
sulfamethoxazole (1.25/ 23.75 µg), ceftriaxone (30 µg), 
ciprofloxacin (5 µg), gentamicin (10 µg), amikacin (30 
µg), cefoperazone-sulbactam (75/ 30 µg), imipenem (10 
µg) and meropenem (10 µg). Concurrent quality control 
testing was performed with Escherichia coli ATCC 25922 
and Pseudomonas aeruginosa ATCC 27853. After 
overnight incubation, the diameter of each zone of 
inhibition around the antimicrobial disk was measured. 
The susceptibility results were interpreted according to 
recommendations of CLSI as sensitive, intermediate and 
resistant.7 The data were entered and analyzed using 
SPSS version 19. For qualitative variables (Gram-
negative bacilli, gender, type of samples and organisms 
isolated) frequencies and percentages were calculated. 
Mean ± SD was presented for age.  
R e s u l t s  
A total of one hundred and forty-four (144) isolates of 
Gram-negative bacilli were included in the study. Majority 
of isolates were yielded from urine (n=83, 57.6%), 
followed by pus (n=23, 16%) and respiratory specimens 
(n=17, 11.9%). The other isolates were from blood, high 
vaginal swabs, catheter tips, ear swabs, tissue and body 
fluids. The distribution of specimens along with their 
breakup is presented in table 1. Out of one hundred and 
forty-four (144) Gram-negative bacilli, one hundred 
(69.44%) were members of the family Enterobacteriaceae  
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Figure 1: Frequency of isolated gram-negative bacilli 
(n=144) 
 
and forty-four (30.56%) were from non-
Enterobacteriaceae. and forty-four (30.56%) were from 
non-Enterobacteriaceae. 
The commonest isolated organism was Escherichia coli 
(47.3%), followed by Pseudomonas aeruginosa (17.36%) 
and Acinetobacterbaumannii (13.19%). (Figure-1) Out of 
one hundred and forty-four isolates, 53.47% were 
recovered from male patients and 46.53% from female 
patients. Mean age of the patients was 49.32years+ 23.72 
SD. Age distribution of different age groups  which yielded 
Gram-negative isolates is shown in Figure-2. 
 
 
Figure 2: Distribution of different age groups, which 
yielded gram- negative bacilli 
 
Thirty-seven isolates (33.3%) were isolated from outdoor 
patients, while the remaining (n=107, 66.7%) were from 
patients admitted in different wards. Their distribution is 
presented in Figure 3. 
The resistance frequency of E.coli against ampicillin, 
amoxicillin-clavulanate and trimethoprim-
sulfamethoxazole was 93.3%, 81.3% and 76% 
respectively. None of the isolates was 100% susceptible 
to any of the antimicrobials assessed in the study.
Table 1: Break up of clinical specimens yielding 
gram-negative bacilli (n=144) 
 Frequency Percentage 







CVP 1 .7 
CSF 1 .7 
Vitreous tap 1 .7 
Bile 1 .7 




Peritoneal fluid 2 1.4 




Sputum 2 1.4 
Catheter tips 4 2.8 
Pus 23 16.0 
Ear swab 1 .7 
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Table 2: Antimicrobial resistance pattern in Enterobacteriaceae 








 n R% n R% n R% n R% 
AMP 70 93.3 15 100 7 87.5 2 100 
AMC 61 81.3 14 93.3 7 87.5 2 100 
AK 14 18.6 7 46.6 3 37.5 2 100 
G 32 42.6 8 53.3 3 37.5 1 50 
COT 57 76 11 73.3 6 75 2 100 
CRO 51 68 11 73.3 4 50 1 50 
IMP 17 22.6 8 53.3 1 12.5 1 50 
MNP 21 28 8 53.3 2 25 1 50 
SCF 10 13.3 5 33.3 2 25 1 50 
CIP 51 68 8 53.3 3 37.5 1 50 
 
The antibiotic susceptibility pattern of members of 
Enterobacteriaceae, including E.coli, K.pneumoniae, 
Enterobacter sp and Proteus mirabilis has been shown in 
Table 2.  
 
Figure-3: Sites of collection of gram-negative bacilli. 
 
 
The susceptibility pattern of members of non-
Enterobacteriaceae including Pseudomonas aeruginosa 
and Acinetobacter baumannii is displayed in Table 3.  
 








 n R% n R% 
AMP _ _ 19 100 
AMC _ _ 19 100 
AK 13 52 15 78.9 
G 20 80 17 89.4 
COT _ _ 18 94.7 
CRO _ _ 17 89.4 
CAZ 24 96 _ _ 
IMP 13 52 18 94.7 
MNP 13 52 18 94.7 
CIP 18 72 17 89.4 
SCF 12 48 12 63.1 
DOX _ _ 13 68.4 
AMP-Ampicillin, AMC-Amoxicillin-clavulanate, AK-
Amikacin, G-Gentamicin, COT-Trimethoprim-
sulfamethoxazole ,  CRO- Ceftriaxone, CAZ- Ceftazidime,  
IMP- Imipenem , MNP- Meropenem, SCF- Cefoperazone-
sulbactam , CIP- Ciprofloxacin ,DOX- Doxycycline, R- 
Resistant 
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D i s c u s s i o n  
The susceptibility pattern of Gram-negative isolates 
revealed an alarming resistance ratio to commonly used 
antibiotics. In the present study, E.coli, Klebsiella 
pneumoniae, Enterobacter spp and Proteus mirabilis are 
highly resistant to first-line drugs including ampicillin, 
trimethoprim-sulfamethoxazole and amoxicillin-
clavulanate. These findings are in agreement with a study 
carried out at Fauji Foundation Hospital Rawalpindi by 
Nabi et al.8 It is worrisome to note the high rates of 
resistance of members of Enterobacteriaceae to the third 
generation cephalosporins (ceftriaxone) and also to the 
commonly used flouroquinolone (ciprofloxacin) in our 
study. Similar resistance patterns have been reported in 
other studies from Rawalpindi4 as well as from Iran.9 This 
situation is much different when compared to the 
resistance rate prevailing in England as published in 
English surveillance programme for antimicrobial 
utilization and resistance (ESPAUR) report, 2014.10 The 
contrasting results provide an evidence of injudicious and 
imprudent use of these antibiotics in our setup. 
The resistance frequency of E.coli against gentamicin 
(42.67%) and amikacin(18.67%) is comparable to a study 
conducted on uropathogens by Nabi et al in Dhaka in 
2014.11 A low percentage of resistance of E.coli against 
amikacin indicate that this antibiotic may be a useful 
therapeutic agent in our  setup  when considered as 
empirical choice.  Klebsiella pneumoniae is fairly resistant 
to gentamicin and amikacin. This finding is in 
concordance with those reported by Bhat et al.12 A high 
and moderate level of resistance of Proteus mirabilis 
against amikacin and gentamicin respectively are 
depicted in our study, a situation different from the one 
reported by Bahashwan et al.13 A disturbing situation 
existing in our hospital is 53.3% resistance against 
imipenem and meropenem conferred by K.pneumoniae,  
and 50% for both members of carbapenems by 
P.mirabilis. Similar results have been reported from other 
parts of the subcontinent.11,13 Poor infection control 
measures contribute to the development of high-level 
resistance to these relatively safe and effective antibiotics. 
Resistance of E.coli and Enterobacter spp against 
carbapenems are also significantly high when compared 
to studies conducted in two different institutions at 
Rawalpindi.4,8 Our study also revealed A.baumannii is 
significantly resistant (89.4%) to each of ceftriaxone, 
gentamicin  and ciprofloxacin. This bug shows 94.4% 
resistance to carbapenems and trimethoprim-
sulfamethoxazole. The resistance pattern in our settings 
is in accordance when compared to data by Fayyaz et al16 
in Rawalpindi and Sohail et al in Lahore.17 Cefoperazone-
sulbactam and doxycycline are relatively effective drugs 
against A.baumannii (63.1% & 68.4% respectively) in our 
setting , which is a similar finding as demonstrated  by 
Fayyaz et al.16 Our data suggests 96% resistance of 
P.aeruginosa against ceftazidime, 72% against 
ciprofloxacin  and  52%  against amikacin , imipenem and 
meropenem respectively. Comparison with ESPAUR 
report revealed a stupendous difference in susceptibility 
pattern of P.aeruginosa, indicative of a failure of antibiotic 
stewardship in our settings.10 Antibiograms in context to 
local data unveiled an increased resistance ratio to 
antipseudomonal antibiotics as compared to our clinical 
settings.4,18 Our study is laboratory-based and has no 
correlation with the clinical outcomes after antibiotics 
administration to treat the specific pathogen. Despite this 
limitation, the study will be helpful for local clinicians to 
make an appropriate choice of antibiotic for empirical 
therapy. 
C o n c l u s i o n  
E.coli is the most common Gram-negative bacillus, 
followed by P.aeruginosa and A.baumannii isolated from 
the culture of clinical specimens in POF Hospital, Wah. 
The isolates depict highly resistant patterns to available 
oral antibiotics as well as commonly prescribed injectable 
third generation cephalosporins and carbapenems. 
1. Gram-negative bacilli reveal relatively better 
susceptibility against Cefoperazone-sulbactam.  
2. Antibiotic resistance is a dynamic phenomenon 
which emphasizes continuous monitoring of 
infection control practices and regular surveillance 
of antibiotics susceptibility patterns in our health 
care setting.  
3. Strict implementation of polices for judicious use of 
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